---
title: "Mendelian Randomization Study: Neuroticism, Modifiable Mediators, and Alzheimer’s Disease Risk"
id: "medrxiv-0-investigating-the-causal-relationship-between-neuroticism-and-alzheimer-s"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-investigating-the-causal-relationship-between-neuroticism-and-alzheimer-s"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1?rss=1"
published_at: "2026-08-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Mendelian Randomization Study: Neuroticism, Modifiable Mediators, and Alzheimer’s Disease Risk
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-investigating-the-causal-relationship-between-neuroticism-and-alzheimer-s
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1?rss=1)
- **Published At:** 2026-08-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study assessed whether the association between **neuroticism** and **Alzheimer's disease (AD)** is causal and whether modifiable health and behavioral factors mediate this relationship. - A two-sample Mendelian randomization (MR) analysis used published GWAS summary statistics for neuroticism (Nagel et al., 2018) and AD (Bellenguez et al., 2022). - MR results indicated the neuroticism–AD link is unlikely to be causal based on genetic instrument analyses. - Mediation analysis used a subset of UK Biobank participants aged 60 and older with complete data on neuroticism and candidate mediators: 121,825 controls (mean age 63.9 ± 2.81; 50.9% female) and 1,277 AD cases (mean age 65.6 ± 2.71; 49.2% female). - Three modifiable mediators were identified as significant: **depression** (β = 0.048, p = 3×10−4), **hypertension** (β = 0.005, p = 2×10−4), and **alcohol consumption** (β = 0.001, p = 1×10−5). - The authors conclude that the observed association between neuroticism and AD may be largely explained by these modifiable health and behavioral factors rather than a direct causal effect of neuroticism. - Data produced in the study are available on reasonable request; the preprint has not been peer reviewed and should not guide clinical practice. - Ethical approvals: UK Biobank approval by the Northwest Multi-Centre Research Ethics Committee; data accessed under application #61530 with Centre for Addiction and Mental Health as lead institution.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=3d0NF9HZyE0zy0PI0xiLCmAqZV4ehGsL0DBvhmINsfU-1785853808.9876306-1.2.1.1-Bi7efF.FnKXUQcoGPgBjqoAVURZM558w3mVyRBEJb8k) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Investigating the Causal Relationship between Neuroticism and Alzheimer's Disease Using Mendelian Randomization and the Mediating Role of Modifiable Risk Factors Niki Akbarian, Mahbod Ebrahimi, Fernanda C Dos Santos, Sara Sadat Afjeh, Mohamed Abdelhack, Andreea Diaconescu, Daniel Felsky, Clement Zai, James Kennedy doi: https://doi.org/10.64898/2026.08.01.26359481 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Niki Akbarian 1 University of Toronto; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Niki%2BAkbarian%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Akbarian%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANiki%2BAkbarian%2B) * For correspondence: niki.akbarian@alumni.utoronto.ca Mahbod Ebrahimi 1 University of Toronto; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mahbod%2BEbrahimi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ebrahimi%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMahbod%2BEbrahimi%2B) Fernanda C Dos Santos 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Fernanda%2BC%2BDos%2BSantos%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dos%20Santos%20FC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFernanda%2BC%2BDos%2BSantos%2B) Sara Sadat Afjeh 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sara%2BSadat%2BAfjeh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Afjeh%20SS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASara%2BSadat%2BAfjeh%2B) Mohamed Abdelhack 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mohamed%2BAbdelhack%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Abdelhack%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMohamed%2BAbdelhack%2B) Andreea Diaconescu 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andreea%2BDiaconescu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Diaconescu%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndreea%2BDiaconescu%2B) Daniel Felsky 3 CAMH: Centre for Addiction and Mental Health * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Daniel%2BFelsky%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Felsky%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADaniel%2BFelsky%2B) Clement Zai 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Clement%2BZai%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zai%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClement%2BZai%2B) James Kennedy 2 Centre for Addiction and Mental Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=James%2BKennedy%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kennedy%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJames%2BKennedy%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1271672/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1271672/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1271672/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1271672/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1271672/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Neuroticism, a personality trait characterized by the predisposition to experience intense and frequent negative emotions, has been associated with an increased risk of Alzheimer's disease (AD). However, the mechanisms underlying this association remain unclear. Our study investigated two potential pathways: (1) whether the relationship between neuroticism and AD is causal, and (2) whether it is mediated by health and behavioral factors associated with both neuroticism and AD risk. To assess causality, a two-sample Mendelian randomization (MR) was employed using publicly available genome-wide association studies (GWAS) for neuroticism (Nagel et al., 2018) and AD (Bellenguez et al., 2022). Mediation analysis was conducted in a subset of UK Biobank participants aged 60 and older, including 121,825 controls (mean age = 63.9 ± 2.81; 61,993 females or 50.9%) and 1,277 individuals with AD (mean age = 65.6 ± 2.71; 628 females or 49.2%). All participants had complete data on neuroticism and the potential mediators. MR analysis suggested that the neuroticism-AD relationship is unlikely to be causal. However, depression (β=0.048, p=3×10-4), hypertension (β=0.005, p=2×10-4), and alcohol consumption (β=0.001, p=1×10-5) were identified as significant mediators of the relationship between higher neuroticism and increased AD risk. Overall, the association between neuroticism and AD may be largely explained by modifiable health and behavioral factors rather than a direct causal effect. A better understanding of these mediating pathways may inform targeted prevention and therapeutic strategies to reduce AD risk. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The UK Biobank received ethics approval from the Northwest Multi-Centre Research Ethics Committee. All participants provided written consent to the study, and any participant who withdrew from the study was removed from our analysis. The data was accessed under the application #61530 with the Centre for Addiction and Mental Health as the lead institution. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-ND 4.0 International license](http://creativecommons.org/licenses/by-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.04.14.26348906v2 "Trans-Aqueduct Access to the Third Ventricle for Delivery of Medical Devices: A Feasibility Study") Posted August 04, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/04/2026.08.01.26359481.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.01.26359481v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/04/2026.08.01.26359481.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Investigating the Causal Relationship between Neuroticism and Alzheimer's Disease Using Mendelian Randomization and the Mediating Role of Modifiable Risk Factors Niki Akbarian, Mahbod Ebrahimi, Fernanda C Dos Santos, Sara Sadat Afjeh, Mohamed Abdelhack, Andreea Diaconescu, Daniel Felsky, Clement Zai, James Kennedy medRxiv 2026.08.01.26359481; doi: https://doi.org/10.64898/2026.08.01.26359481 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.01.26359481v1%26text%3DInvestigating%2520the%2520Causal%2520Relationship%2520between%2520Neuroticism%2520and%2520Alzheimer%2527s%2520Disease%2520Using%2520Mendelian%2520Randomization%2520and%2520the%2520Mediating%2520Role%2520of%2520Modifiable%2520Risk%2520Factors "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.01.26359481v1%26t%3DInvestigating%2520the%2520Causal%2520Relationship%2520between%2520Neuroticism%2520and%2520Alzheimer%2527s%2520Disease%2520Using%2520Mendelian%2520Randomization%2520and%2520the%2520Mediating%2520Role%2520of%2520Modifiable%2520Risk%2520Factors "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.01.26359481v1%26title%3DInvestigating%2520the%2520Causal%2520Relationship%2520between%2520Neuroticism%2520and%2520Alzheimer%2527s%2520Disease%2520Using%2520Mendelian%2520Randomization%2520and%2520the%2520Mediating%2520Role%2520of%2520Modifiable%2520Risk%2520Factors%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.01.26359481v1%26title%3DInvestigating%2520the%2520Causal%2520Relationship%2520between%2520Neuroticism%2520and%2520Alzheimer%2527s%2520Disease%2520Using%2520Mendelian%2520Randomization%2520and%2520the%2520Mediating%2520Role%2520of%2520Modifiable%2520Risk%2520Factors "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.01.26359481) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.01.26359481v1&count=horizontal&via=&text=Investigating%20the%20Causal%20Relationship%20between%20Neuroticism%20and%20Alzheimer%27s%20Disease%20Using%20Mendelian%20Randomization%20and%20the%20Mediating%20Role%20of%20Modifiable%20Risk%20Factors&counturl=www.medrxiv.org/content/10.64898/2026.08.01.26359481v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (594) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (888) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (322) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4683) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (466) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (403) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (631) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1596) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15652) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1179) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6881) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (717) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1035) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4859) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1413) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1699) * [Hematology](https://www.medrxiv.org/collection/hematology) (568) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1306) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16148) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1145) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (651) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (148) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (705) * [Neurology](https://www.medrxiv.org/collection/neurology) (7033) * [Nursing](https://www.medrxiv.org/collection/nursing) (357) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1057) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1206) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (988) * [Oncology](https://www.medrxiv.org/collection/oncology) (3510) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1015) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (381) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (433) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (455) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (135) * [Pathology](https://www.medrxiv.org/collection/pathology) (695) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1752) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (724) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (751) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5725) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9553) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2328) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1406) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1229) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (628) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-an
## Related Clinical Research

- [Diet and Alzheimer’s risk: Why no single best diet fits everyone](https://medichelpline.com/clinical-feed/medical-news-today-0-is-there-a-best-diet-to-help-lower-alzheimer-s-risk.md)
- [Prevalence of cognitive impairment in older Palestinian adults in community and nursing homes](https://medichelpline.com/clinical-feed/plos-one-16-prevalence-of-cognitive-impairment-among-older-adult-palestinians-in-community.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [Avoiding smoking, diabetes, and high blood pressure in midlife may add up to 13 dementia-free years](https://medichelpline.com/clinical-feed/medical-news-today-0-avoiding-3-risk-factors-in-midlife-could-add-13-dementia-free-years.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.